• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

Betamethasone is a synthetic glucocorticoid corticosteroid with potent anti-inflammatory and immunosuppressive properties. It is widely used in clinical medicine to treat a variety of conditions, ranging from dermatological disorders to rheumatic diseases, respiratory illnesses, and certain types of cancer. This report provides a concise yet detailed examination of betamethasone, covering its pharmacology, therapeutic applications, adverse effects, and clinical considerations.

Chemistry and Mechanism of Action

Betamethasone is a fluorinated corticosteroid, structurally similar to prednisolone but with enhanced potency. It is available in several salt forms, including betamethasone sodium phosphate (soluble) and betamethasone acetate (suspension), as well as esterified versions like betamethasone valerate and betamethasone dipropionate for topical use. The drug exerts its effects primarily by binding to the glucocorticoid receptor (GR), which then translocates to the nucleus and modulates gene transcription. This leads to increased synthesis of anti-inflammatory proteins (e.g., lipocortin-1) and decreased production of pro-inflammatory mediators such as prostaglandins, leukotrienes, and cytokines. Betamethasone also suppresses immune cell migration and activity, including that of T‑cells, macrophages, and mast cells.

Pharmacokinetics

Given orally, betamethasone is rapidly absorbed with a bioavailability of approximately 100%. Its plasma half-life ranges from 3 to 5 hours, but its biological half-life is longer (36–54 hours) due to its high affinity for the glucocorticoid receptor. The drug is extensively metabolized in the liver, primarily via CYP3A4, and excreted in urine. For topical formulations, systemic absorption is minimal but can be significant with prolonged use on large areas or under occlusion. Betamethasone crosses the placenta and is excreted in breast milk, necessitating caution during pregnancy and lactation.

Therapeutic Uses

Betamethasone is employed across multiple medical specialties:

• Dermatology: Topical betamethasone (valerate or dipropionate) is a mainstay for inflammatory skin conditions such as psoriasis, eczema, contact dermatitis, and seborrheic dermatitis. It is available in creams, ointments, lotions, and foams. Potency varies by concentration and vehicle; it is classified as a high-potency corticosteroid.
  
  
• Rheumatology and Orthopedics: Injectable forms (often combined betamethasone sodium phosphate and acetate) are used for intra-articular or soft‑tissue administration to manage osteoarthritis, rheumatoid arthritis, bursitis, tendinitis, and gout. The rapid-acting phosphate provides quick relief, while the acetate sustains effect for weeks.
  
  
• Respiratory Medicine: Betamethasone is used in nebulized form for acute asthma exacerbations and may be given parenterally for severe croup or chronic obstructive pulmonary disease (COPD). It reduces airway inflammation and bronchial hyperreactivity.
  
  
• Obstetrics: Betamethasone is critical for accelerating fetal lung maturation in women at risk of preterm delivery between 24 and 34 weeks of gestation. A typical course (two doses of 12 mg intramuscularly, 24 hours apart) significantly reduces the incidence of neonatal respiratory distress syndrome (RDS) as well as intraventricular hemorrhage and necrotizing enterocolitis.
  
  
• Oncology: Betamethasone is part of antiemetic regimens for chemotherapy-induced nausea and vomiting (CINV), often combined with a 5‑HT3 antagonist. It also manages edema in brain tumors due to its ability to reduce peritumoral vasogenic edema.
  
  
• Allergy and Immunology: Systemic betamethasone is used for severe allergic reactions, anaphylaxis, and autoimmune disorders (e.g., lupus, vasculitis). It suppresses immune response and reduces vascular permeability.
  
  

Adverse Effects

Short‑term use (< 3 weeks) is generally well tolerated, but prolonged systemic administration carries significant risks, mirroring those of other glucocorticoids:

• Metabolic: Hyperglycemia, diabetes mellitus, weight gain, central obesity, Cushingoid features (moon face, buffalo hump), and osteoporosis.
  
• Cardiovascular: Hypertension, fluid retention, (https://redpark.es) and increased risk of thromboembolism.
  
• Gastrointestinal: Gastric ulceration, pancreatitis, and esophageal candidiasis.
  
• Musculoskeletal: Myopathy, osteonecrosis (especially femoral head), and growth suppression in children.
  
• Immunologic: Increased susceptibility to infections (including reactivation of tuberculosis, herpes zoster) and impaired wound healing.
  
• Neuropsychiatric: Mood changes, insomnia, psychosis, and pseudotumor cerebri.
  
• Endocrine: Adrenal suppression (HPA axis suppression) requiring slow tapering after discontinuation.
  
  

Topical use may cause skin atrophy, striae, telangiectasias, perioral dermatitis, and, rarely, systemic effects if applied extensively.

Contraindications and Precautions

Betamethasone should be used cautiously in patients with systemic fungal infections (except for acute infections where corticosteroid therapy is adjunctive), known hypersensitivity, peptic ulcer disease, osteoporosis, diabetes mellitus, hypertension, psychiatric disorders, and recent myocardial infarction. Live vaccines are contraindicated during high‑dose therapy. In pregnancy, betamethasone is used for fetal lung maturation but should otherwise be avoided unless the benefit outweighs risk.

Drug Interactions

Betamethasone is metabolized by CYP3A4; inducers (e.g., rifampin, phenytoin, carbamazepine) reduce its efficacy, while inhibitors (e.g., ketoconazole, ritonavir) may increase toxicity. Concomitant use with NSAIDs increases gastrointestinal bleeding risk. Hypokalemia may be exacerbated with diuretics or amphotericin B.

Special Populations

• Pediatric: Monitor growth; use lowest effective dose.
  
• Geriatric: Increased risk of osteoporosis, diabetes, and infections.
  
• Hepatic/Renal impairment: No major dose adjustment needed, but caution in severe hepatic impairment.
  
  

Clinical Pearls

• For acute asthma or severe inflammatory conditions, betamethasone is preferred over dexamethasone due to slightly different mineralocorticoid activity (negligible) but similar potency.
  
• Intra-articular injections should be performed under aseptic technique; repeat injections no more frequently than every 3–4 weeks.
  
• To minimize HPA suppression, use single daily morning dosing for oral therapy.
  
• Topical potency varies: betamethasone dipropionate 0.05% cream is considered high-strength, suitable for short‑term use on limited areas.
  
  

Conclusion

Betamethasone remains an indispensable corticosteroid in modern medicine, offering powerful anti-inflammatory and immunosuppressive effects across a broad range of conditions. Its efficacy in accelerating fetal lung maturation is a life‑saving intervention in preterm labor. However, like all potent glucocorticoids, it demands careful risk‑benefit analysis, appropriate dosing, and monitoring for adverse effects. Clinicians must be well versed in its pharmacology, indications, and potential complications to optimize patient outcomes.